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Despite tea increased plasma nonenzymatic antioxidant capacity, the European Food Safety Administration (EFSA) denied claims
related to tea and its protection from oxidative damage. Furthermore, the Supplement Information Expert Committee (DSI EC)
expressed some doubts on the safety of green tea extract (GTE).We performed a pilot study in order to evaluate the effect of a single
dose of two capsules of a GTE supplement (200mg × 2) on the peroxidation of leukocytes index ratio (PLIR) in relation to uric acid
(UA) and ferric reducing antioxidant potential (FRAP), as well as the sample size to reach statistical significance. GTE induced a
prooxidant effect on leukocytes, whereas FRAP did not change, in agreement with the EFSA and the DSI EC conclusions. Besides,
our results confirm the primary role of UA in the antioxidant defences. The ratio based calculation of the PLIR reduced the sample
size to reach statistical significance, compared to the resistance to an exogenous oxidative stress and to the functional capacity of
oxidative burst. Therefore, PLIR could be a sensitive marker of redox status.
1. Introduction
The Supplement Information Expert Committee (DSI EC)
indicated that consumption of green tea extract (GTE) could
induce liver damage [1]. In fact, there are an increasing num-
ber of case reports of hepatotoxicity in humans associated
with intake of green tea (GT) dietary supplements [2–7]. The
types of preparation responsible for the adverse effects were
hydroalcoholic extract and aqueous extract of GT, consumed
as tea or in capsules [7]. However, there are also cases report-
ing hepatotoxicity after GT infusion [2–7]. In particular, a
case has been reported with features mimicking autoimmune
hepatitis, with abnormal liver histology and elevated levels of
aspartate aminotransferase, alanine aminotransferase, alka-
line phosphatase, gamma glutamyl-transferase and bilirubin,
associated with hypergammaglobulinemia, and the transient
presence of anti-smooth-muscle antibodies (ASMA) and
anti-neutrophil cytoplasmic antibodies (ANCA) [8]. GT
withdrawal resulted in a slow and continuous improvement
with a complete resolution after 7 months [8].
Furthermore, the Food and Drug Administration (FDA)
and the European Food Safety Administration (EFSA) have
denied the proposed health claims for GT and decreased
risk of noncommunicable diseases [9]. In particular, despite
GT increased plasma nonenzymatic antioxidant capacity
(NEAC) [10], the EFSA denied claims related to tea and
protection of DNA and lipids from oxidative damage [9].
GT contains several flavonoids with antioxidant proper-
ties, in particular the flavanol monomers known as catechins,
where epigallocatechin-3-gallate (EGCG) is themost effective
antioxidant compound [11]. However, tea catechins could
have also prooxidant activity [11]. Besides, some of the
protective effects of EGCGhave been ascribed to its capability
to reduce excessive uric acid (UA) level [12]. In particular,
flavanols ofCamellia sinensismodulate both xanthine oxidase
and urate transport [13]. UA is the major plasma antioxidant
and contributes to plasmanonenzymatic antioxidant capacity
[10].
The peroxidation of leukocytes index ratio (PLIR) mea-
sures the resistance of leukocytes to exogenous oxidative
stress and their functional capacity of oxidative burst upon
activation [14].
Therefore, we performed a pilot study in order to evaluate
the effect of a single dose of a GTE supplement on the PLIR,
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in relation to plasma UA and ferric reducing antioxidant
potential (FRAP) [15], as well as the sample size to reach
statistical significance.
2. Material and Methods
2.1. Subjects and Treatment. Participants (6 men and 4
women, 19–35 years old) to the study, who volunteered in
response to advertisements, were healthy, nonsmokers and
were taking no supplements.
For two days prior to each feeding study the subjects
followed a low antioxidant diet (washout) by avoiding all
fresh fruit, vegetables, tea, coffee, cocoa, fruit juices, andwine.
On the day of the study, after an overnight fast, venous
blood samples were collected (in EDTA-tubes) before (T0),
30 minutes (T0.5), and 3 hours (T3) after a single dose
of two capsules of a GTE (200mg × 2), commercially
available in Italy (cod. 1820, REGISTRO INTEGRATORI
https://www.salute.gov.it/imgs/C 17 pagineAree 3668
listaFile itemName 1 file.pdf).
2.2. Plasma Uric Acid and TAC. The plasma was separated
by centrifugation at 1300×g at 4∘C for 15min and stored at –
80∘C. Plasma levels of UA were quantified using colorimetric
kits (Sentinel CH. SpA, Italy).
Plasma TAC was measured with the FRAP assay [15]. We
calculated also the uric acid- independent FRAP (FRAP-UA)
as previously described [16], applying the formula:
FRAP-UA = FRAP 𝜇M − 2UA𝜇M. (1)
2.3. PLIR Method. After red blood cells’ lysis and 4,4-
difluoro-5-(4-phenyl-1,3-butadienyl)-4-bora-3a,4a-diaza-
s-indacene-3-undecanoic acid (C11-BODIPY, Invitrogen,
final concentration 1𝜇M) staining, leukocytes were treated
as previously described [14, 17] with phorbol 12-myristate
13-acetate (PMA, Sigma, final concentration 1 𝜇g/mL), 2,2󸀠-
azobis(2-methylpropionamidine) dihydrochloride (AAPH,
Sigma, final concentration 10mM), 6-hydroxy-2,5,7,8-
tetramethylchroman-2-carboxylic acid (Trolox, Sigma, final
concentration 10𝜇M), PMA 1 𝜇g/mL + Trolox 10 𝜇M, or
AAPH 10mM + Trolox 10 𝜇M. After 30min at 37∘C cells
were stored in ice, to stop reactions, and rapidly analyzed on
an Accuri C6 BD cytometer.
Data acquired on the Accuri C6 was exported in FCS
format and analyzed by FCS express software (De Novo
Software) to calculate the ratio of oxidation of the probe C11-
BODIPY (FL1/FL2).
PLIR was calculated as previously described [14, 17],
applying the formula:
PLIR = (ratio AAPH × ratio PMA Trolox)
(ratio AAPH Trolox × ratio PMA)
. (2)
2.4. Statistics. Statistical analysis, carried out with Friedman
RM ANOVA on Ranks, revealed a normal distribution for
all markers (Normality Test Shapiro-Wilk and Equal variance
test passed).
Table 1: Effect of GTE consumption on plasma antioxidant markers
and PLIR.
T0 T0.5 T3
UA 𝜇M 334.1 ± 7.4 324.9 ± 3.9 324.3 ± 3.7
FRAP 𝜇M 1061.5 ± 38.45 1061.48 ± 52.85 1083.33 ± 46.78
FRAP-UA 𝜇M 393.23 ± 41.63∗ 411,57 ± 53.38 434.59 ± 41,75∗
PLIR L 2.09 ± 0.17 2.09 ± 0.17 2.37 ± 0.19
PLIRM 1.88 ± 0.13∗ 1.86 ± 0.12 2.19 ± 0.15∗
PLIRG 1.80 ± 0.12∗ 1.90 ± 0.14 2.17 ± 0.15∗
Plasma antioxidant markers in samples collected from 10 healthy subjects
before (T0), 0.5 (T0.5), and 3 hours (T3) after the consumption of a single
dose of two capsules of a green tea extract (GTE) supplement (200mg ×
2). UA: uric acid, FRAP: ferric reducing antioxidant potential, FRAP-UA:
uric acid-independent FRAP, PLIR: peroxidation of leukocytes index ratio,
L: lymphocytes, M: monocytes, and G: granulocytes. RM ANOVA, with
time as within-subjects factor, followed by Student-Newman-Keuls post hoc
analysis: T3 versus T0: ∗𝑝 < 0.05.
Therefore, statistical analysis was carried out with
repeated measures analysis of variance (RM ANOVA),
with time or treatment as within-subjects factors. Student-
Newman-Keuls post hoc analysis (all pairwise multiple com-
parison procedure) was used to isolate differences between
groups. Spearman correlation was used to evaluate relation-
ships between variables. All statistical evaluations were per-
formed using the SigmaStat and SigmaPlot software (Jandel
Scientific, Inc.).
3. Results
3.1. Plasma Uric Acid and TAC. RM ANOVA, with time
as within-subjects factor, followed by Student-Newman-
Keuls post hoc analysis (all pairwise multiple comparison
procedure), revealed that GTE consumption did not affect
FRAP values, whereas 3 hours (T3) after treatment both a
nonsignificant decrease in UA and a significant increase in
FRAP-UA were found (Table 1).
From the difference of means and the standard deviations
(power 0.8; alpha 0.05) we calculated a sample size (to reach
statistical significance) of 106 for UA.
3.2. PLIR Method. Treatment with GTE significantly incre-
ased PLIR of monocytes and granulocytes at T3, whereas a
nonsignificant increase was observed for PLIR of lympho-
cytes (Table 1).We calculated a sample size (to reach statistical
significance) of 80 for PLIR of lymphocytes.
Pearson ProductMoment Correlation revealed an inverse
correlation of UA with PLIR L (CC = −0.383, 𝑝 = 0.0368),
PLIRM (CC = −0.474, 𝑝 = 0.008), and PLIRG (CC = −0.545,
𝑝 = 0.001) and a direct correlation of FRAP-UA with PLIR
L (CC = 0.451, 𝑝 = 0.012), PLIR M (CC = 0.398, 𝑝 = 0.029),
and PLIR G (CC = 0.434, 𝑝 = 0.016).
3.3. Ratio of Oxidation of the Probe C11-BODIPY. Typical
overlay dot plots of the four treatments used for PLIR
calculation and ratio of fluorescence (FL1/FL2) on single cells,
before GTE consumption and 3 hours after, are presented in
Figures 1 and 2, respectively.
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Figure 1: Typical overlay dot plots of ratio (ratio of oxidation of the probe C11-BODIPY: FL1/FL2) versus side scatter (SSC): before (T0) and
3 hours (T3) in leukocytes collected after a single dose of two capsules of a green tea extract (GTE) supplement (200mg × 2). L: lymphocytes,
M: monocytes, and G: granulocytes. Unstimulated samples (black) and leukocytes treated with 2,2󸀠-azobis(2-methylpropionamidine)
dihydrochloride (AAPH, 10mM, red), AAPH (10mM) + 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (Trolox, 10 𝜇M, yellow),
phorbol 12-myristate 13-acetate (PMA, 1 𝜇g/mL, blue), or PMA (1 𝜇g/mL) + Trolox (green).
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Figure 2: Ratio (ratio of oxidation of the probe C11-BODIPY: FL1/FL2) of monocytes (a) and granulocytes (b), in samples collected from
10 healthy subjects before (T0) and 3 hours (T3) after the consumption of a single dose of two capsules of a green tea extract (GTE)
supplement (200mg × 2). Cells unstimulated (UNST) or treated with phorbol 12-myristate 13-acetate (PMA, 1 𝜇g/mL), 2,2󸀠-azobis(2-
methylpropionamidine) dihydrochloride (AAPH, 10mM), 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (Trolox, 10 𝜇M), Trolox
+ PMA, or Trolox + AAPH. Two-way (2W) RMANOVA, with time and treatment as within-subjects factors, followed by Student-Newman-
Keuls post hoc analysis: AAPH versus PMA within time: ∗∗𝑝 < 0.01, ∗∗∗𝑝 < 0.001.
Trolox inhibited the peroxidation of C11-BODIPY in
leukocytes exposed to AAPH free radicals generating system,
but not the PMA-induced oxidation in monocytes and
granulocytes, both at T3 and at T0 (Figure 1).
Considering the major components of PLIR affected
by treatment, compared to baseline, the AAPH-induced
(exogenous) oxidation appeared greater, whereas the PMA-
induced oxidative burst appeared lower (Figure 1).
Despite the differences of ratio PMA and ratio AAPH
between times did not reach significance, the statistical sig-
nificance between ratioAAPHand ratio PMAwas different at
baseline and at T3 on granulocytes andmonocytes (Figure 2).
We calculated a sample size (to reach statistical significance
between times) of 17 and 33 for ratio AAPH and of 21 and 51
for ratio PMA, for granulocytes and monocytes, respectively.
Ratio PMA was not related to neither UA nor FRAP-UA,
whereas ratio AAPH was inversely correlated with UA on all
cells (L: CC = −0.477, 𝑝 = 0.007; M: CC = −0.514, 𝑝 = 0.003;
G: CC = −0.511, 𝑝 = 0.003), but not with FRAP-UA.
4. Discussion
4.1. Effect of GTE on Plasma Antioxidants. Previous stud-
ies reported decreased, increased, or unchanged UA and
NEAC levels after bolus consumption of EGCG or GTE [18–
22]. EGCG increased in plasma from 30min to 2.6 hours
after GTE consumption, depending on the dose and on
the formulation [21–25]. However, the FRAP value did not
increase when free EGCG concentration was at its peak [21],
probably due to the decrease in UA levels observed after GTE
consumption [22].
In agreement with these results, in our study GTE
consumption did not affect FRAP valueswhereas a nonsignif-
icant decrease in UA and a significant increase in FRAP-UA
were found 3 hours after treatment. The increase in FRAP-
UA, probably due to the catechins, could counterbalance the
reduction in FRAP induced by theUAdecrease. However, the
FRAP assay matches the antioxidant capacity to the reducing
ability [15] and the reduced iron is critical in the onset of
oxidative stress due to the Fenton reaction that generates the
hydroxyl radical initiator of lipid peroxidation [26].
Therefore, an increase in the metal reducing power could
be more likely detrimental than beneficial.
4.2. Effect of GTE on AAPH-Induced Lipoperoxidation. The
increase in FRAP-UA was temporally associated with an
increased oxidation of the fluorescent probe C11-BODIPY
incorporated into the leukocytes. In this context, the proox-
idant effects of tea catechins on cells are supported by the
molecular mechanisms involved in their induction of antiox-
idant enzymes, through the antioxidant responsive elements
(ARE) pathway [11, 27]. In particular, it has been suggested
that some derivatives of catechins can oxidize highly reactive
cysteine thiol groups of Kelch-like ECH-associated protein-
1 (Keap1), resulting in disulfide bond formation and nuclear
factor-erythroid 2-related factor 2 (Nrf2) release [27].
However, the ratio AAPH was inversely correlated with
UAon all cells, but not with FRAP-UA. In agreementwith our
results the consumption for 112 days of a lutein (12mg/d) plus
GTE (200mg/d) supplement did not reduce the oxidation of
the C11-BODIY incorporated into the lipid compartment of
plasma [28].
4.3. Effect of GTE on PMA-Induced Oxidative Burst. We have
found a nonsignificant decrease of PMA-induced lipoperoxi-
dation afterGTE consumption, contrarily with the increase of
the oxidative burst of granulocyte, observed in cyclists when
quercetin was administered with the tea flavanol epigallocat-
echin 3-gallate, by using dihydrorhodamine 123 (DHR123)
as fluorescence probe [29]. However, the post-exercise-
induced decrease in oxidative burst was unaffected after
bolus consumption of the same supplement [29, 30], when
hydroethidine was used as probe [30]. Therefore our results
confirm that the plasmamembraneC-11 BODIPY is a suitable
probe in the evaluation of the effects on the oxidative burst
of flavonoids, which increase DHR123 accumulation [31].
Though the effect of GTE consumption on oxidative burst
requires more subjects to reach statistical significance, our
results are in agreement with the reduction of the p22phox
subunit of the NADPH oxidase observed in hemodialysis
patients after 6 months of treatment with GT [32].
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4.4. Effect of GTE on PLIR. In a postprandial study [17], we
observed that a functional food covered by dark chocolate
and containing glucomannan, inulin, fructooligosaccharides,
and Bacillus coagulans strain GanedenBC30 significantly
improved postprandial metabolic stress (insulin, glucose,
and triglycerides), reduced the postprandial increase of UA,
and improved PLIR of lymphocytes, but not of monocytes
and granulocytes. We suggested that, although PLIR is a
functional index that is independent of baseline levels of
oxidation, measuring the ratio between the resistance to
exogenous and the resistance to endogenous ROS injury, this
ratio calculation could mask the effect of foods that inhibit
both the exogenous ROS injury and the oxidative burst [17].
On the contrary, in the present study, treatment withGTE
significantly increased PLIR of monocytes and granulocytes
at T3 after ingestion, whereas a nonsignificant increase was
observed for PLIR of lymphocytes. An inverse correlation
of UA with PLIR and a direct correlation of FRAP-UA with
PLIR of all leukocytes were found. Therefore, though some
of the protective effects of catechins have been ascribed to
their capability to reduce excessive UA level [12], in our study
the inverse correlation of PLIR with UA levels, in particular
with the ratio AAPH component of PLIR, confirms that UA
is a major circulating antioxidant as suggested by Fabbrini et
al. [33]. Authors [33] reported that rasburicase treatment, in
subjects who had high serum UA concentrations, caused a
marked decrease in plasma FRAP and a significant increase in
urinary isoprostanes/creatinine ratio and in skeletal muscle
protein carbonylation.
On the other hand, though the effects of GTE consump-
tion on oxidative burst and AAPH-induced lipoperoxidation
require more subjects to reach statistical significance, the
statistical significance between ratio AAPH and ratio PMA
was different at baseline and at T3 on granulocytes and
monocytes.Therefore, the ratio based calculation of the PLIR
is able to appreciate differences also with a low number of
subjects in monocytes and granulocytes.
5. Conclusion
In conclusion our study suggests that PLIR, in particular PLIR
of granulocytes where the differences between ratio AAPH
and ratio PMA are more evident, reveals the prooxidant
effect of GTE. The direct correlation of FRAP-UA with PLIR
suggests that the iron reducing power of GTE could be more
likely detrimental than beneficial. This result is in agreement
with the FDA, the EFSA, and the DSI EC conclusions [1,
9]. Furthermore, the inverse correlation of UA with PLIR
confirms the primary role of UA in the antioxidant defences.
Therefore, PLIR could be a sensitive marker of redox status.
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